complete and most recent version of these guidelines, visit NCCN.org ). Staging The TNM classification developed by the AJCC in 2002 was based on pathologic review of the surgical specimen in patients who underwent surgery as primary therapy. The
Search Results
Jaffer A. Ajani, Thomas A. D’Amico, Khaldoun Almhanna, David J. Bentrem, Stephen Besh, Joseph Chao, Prajnan Das, Crystal Denlinger, Paul Fanta, Charles S. Fuchs, Hans Gerdes, Robert E. Glasgow, James A. Hayman, Steven Hochwald, Wayne L. Hofstetter, David H. Ilson, Dawn Jaroszewski, Kory Jasperson, Rajesh N. Keswani, Lawrence R. Kleinberg, W. Michael Korn, Stephen Leong, A. Craig Lockhart, Mary F. Mulcahy, Mark B. Orringer, James A. Posey, George A. Poultsides, Aaron R. Sasson, Walter J. Scott, Vivian E. Strong, Thomas K. Varghese Jr, Mary Kay Washington, Christopher G. Willett, Cameron D. Wright, Debra Zelman, Nicole McMillian, and Hema Sundar
Srinivas K. Tantravahi, and Theresa L. Werner
management of early-stage tumors and treatment failure with isolated local recurrence. In medically operable patients, total hysterectomy, bilateral salpingo-oophorectomy, and pelvic and para-aortic lymph node dissection is the recommended surgery for
Armin Shahrokni, Bella Marie Vishnevsky, Brian Jang, Saman Sarraf, Koshy Alexander, Soo Jung Kim, Robert Downey, Anoushka Afonso, and Beatriz Korc-Grodzicki
Background For many cancers, surgery remains the primary curative treatment. 1 – 3 Geriatric patients experience increased rates of surgical complications compared with younger patients, leading to decreased long-term survival and delayed recovery
Mandy R. Sakamoto, Megan Eguchi, Christine M. Azelby, Jennifer R. Diamond, Christine M. Fisher, Virginia F. Borges, Cathy J. Bradley, and Peter Kabos
prescribing opioids in patients with cancer focus on relieving acute pain or pain associated with advanced disease. 13 – 16 A recent study of patients with cancer undergoing curative-intent surgery found that 10.4% had new persistent opioid use at 1 year
Stephen B. Edge and David G. Sheldon
findings from the National Surgical Adjuvant Breast Project (protocol 6). I. Intraductal carcinoma (DCIS) . Cancer 1986 ; 57 : 197 – 208 . 12 Solin LJ Kurtz J Fourquet A . Fifteen-year results of breast-conserving surgery and definitive
Presenter: Stephen W. Behrman
, Stephen W. Behrman, MD, Professor of Surgery, The University of Tennessee Health Science Center, highlighted the presentation and clinical evaluation of ampullary adenocarcinoma, discussed current management and outcomes, and introduced the inaugural 2022
Scott M. Gilbert and Brent K. Hollenbeck
prospective long-term follow-up study . Surgery 1998 ; 123 : 573 – 578 . 21 Igaki H Tachimori Y Kato H . Improved survival for patients with upper and/or middle mediastinal lymph node metastases of squamous cell carcinoma of the lower thoracic
Alvin R. Cabrera, Kyle C. Cuneo, James J. Vredenburgh, John H. Sampson, and John P. Kirkpatrick
bevacizumab, followed by temozolomide, bevacizumab, and irinotecan (CPT-11). Four weeks after surgery, he began radiotherapy (volumetric modulated arc therapy), receiving 50.4 Gy to the left frontoparietal region with a 9-Gy boost to the tumor bed over 6
Rodger J. Winn
References 1 Vender JR Miller J Rekito A : Effect of hemostasis and electrosurgery in the development and evolution of brain tumor surgery in the late 19 th and 20 th century . Neurosurg Focus 2005 ; 18 : 1 - 7 . 2
Alimujiang Wushou, Meng Wang, Feiluore Yibulayin, Lei Feng, Meng-meng Lu, Yuan Luo, Hui Liu, and Zhi-cheng Yang
Oncology (NCCN Guidelines) for Head and Neck Cancers, 2 surgery is the primary treatment modality for all stages of OSCC, whereas the addition of adjuvant therapeutic regimens, including radiation therapy and chemotherapy, and the use of targeted
